These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 36702111

  • 21. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG.
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [Abstract] [Full Text] [Related]

  • 22. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF, Chiu E, Nessim S, Lok CE, Roscoe JM, Tam P, Jassal SV.
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [Abstract] [Full Text] [Related]

  • 23. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
    Chu KH, Choy WY, Cheung CC, Fung KS, Tang HL, Lee W, Cheuk A, Yim KF, Chan WH, Tong KL.
    Perit Dial Int; 2008 Feb; 28(5):505-8. PubMed ID: 18708544
    [Abstract] [Full Text] [Related]

  • 24. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W, Brauner M, Westphale HJ, Brunkhorst R, Krämer R, Bundschu D, Höffken B, Steinhauer HB, Schümann E, Lüttgen FM, Schillinger-Pokorny E, Schaefer F, Wende R, Offner G, Näther S, Osten B, Zimmering M, Ehrich JH, Kehn M, Mansmann U, Grosse-Siestrup C.
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [Abstract] [Full Text] [Related]

  • 25. Water avoidance and modification of exit-site care with stoma bag results in reduced exit-site infection rate in peritoneal dialysis patients.
    Soetendorp H, Kliuk-Ben Bassat O, Wasserman A, Schwartz D, Bedbalayev R, Faukman I, Grupper A.
    Clin Nephrol; 2021 Jun; 95(6):323-331. PubMed ID: 33835011
    [Abstract] [Full Text] [Related]

  • 26. ISPD Catheter-related Infection Recommendations: 2023 Update.
    Chow KM, Li PK, Cho Y, Abu-Alfa A, Bavanandan S, Brown EA, Cullis B, Edwards D, Ethier I, Hurst H, Ito Y, de Moraes TP, Morelle J, Runnegar N, Saxena A, So SW, Tian N, Johnson DW.
    Perit Dial Int; 2023 May; 43(3):201-219. PubMed ID: 37232412
    [Abstract] [Full Text] [Related]

  • 27. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
    van Diepen AT, Tomlinson GA, Jassal SV.
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
    [Abstract] [Full Text] [Related]

  • 28. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
    Aykut S, Caner C, Ozkan G, Ali C, Tugba A, Zeynep G, Taner C.
    Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
    [Abstract] [Full Text] [Related]

  • 29. Exit site infections: systematic microbiologic and quality control are needed.
    Freitas C, Rodrigues A, Carvalho MJ, Cabrita A.
    Adv Perit Dial; 2009 Jan; 25():26-31. PubMed ID: 19886313
    [Abstract] [Full Text] [Related]

  • 30. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
    Jassal SV, Lok CE, MP3 Study Group.
    Perit Dial Int; 2008 Jan; 28(1):67-72. PubMed ID: 18178950
    [Abstract] [Full Text] [Related]

  • 31. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R.
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [Abstract] [Full Text] [Related]

  • 32. The risk of peritonitis after an exit site infection: a time-matched, case-control study.
    Lloyd A, Tangri N, Shafer LA, Rigatto C, Perl J, Komenda P, Sood MM.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1915-21. PubMed ID: 23382265
    [Abstract] [Full Text] [Related]

  • 33. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
    Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM.
    Perit Dial Int; 2012 Jul; 32(5):525-30. PubMed ID: 22302770
    [Abstract] [Full Text] [Related]

  • 34. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H, Choo JCJ, Johnson DW, Pascoe EM, Jayaballa M, Oei EL, Ng LC, Wu SY, Foo MWY.
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [Abstract] [Full Text] [Related]

  • 35. Staphylococcus aureus infections in dialysis patients: focus on prevention.
    Piraino B.
    ASAIO J; 2000 Apr; 46(6):S13-7. PubMed ID: 11110288
    [Abstract] [Full Text] [Related]

  • 36. Peritoneal catheter exit-site and tunnel infections.
    Piraino B.
    Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
    [Abstract] [Full Text] [Related]

  • 37. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS, Chu KH, Cheuk A, Tsang WK, Fung SK, Chan HW, Tong MK.
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [Abstract] [Full Text] [Related]

  • 38. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS, Sheth H, Piraino B, Bender F.
    Perit Dial Int; 2016 Dec; 36(4):387-9. PubMed ID: 26634567
    [Abstract] [Full Text] [Related]

  • 39. Dialysis: The importance of peritoneal catheter exit-site care.
    Piraino B.
    Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
    [No Abstract] [Full Text] [Related]

  • 40. Exit-Site Relocation: A Novel, Straightforward Technique for Exit-Site Infections.
    Kirmizis D, Bowes E, Ansari B, Cairns H.
    Perit Dial Int; 2019 May; 39(4):350-355. PubMed ID: 31123073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.